ISSN: 0090-8258

Journal Home

Journal Guideline

Gynecologic Oncology Q1 Unclaimed

Academic Press Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Gynecologic Oncology is a journal indexed in SJR in Obstetrics and Gynecology and Oncology with an H index of 157. It has an SJR impact factor of 2,463 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Obstetrics and Gynecology (Q1) Oncology (Q1)

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

2,463

SJR Impact factor

157

H Index

377

Total Docs (Last Year)

1190

Total Docs (3 years)

11215

Total Refs

4978

Total Cites (3 years)

1110

Citable Docs (3 years)

4,3

Cites/Doc (2 years)

29,75

Ref/Doc

Aims and Scope

Other journals with similar parameters

Human Reproduction Update Q1
American Journal of Obstetrics and Gynecology Q1
Ultrasound in Obstetrics and Gynecology Q1
Human Reproduction Q1
Obstetrics and Gynecology Q1

Best articles

A 104-year-old woman with advanced cervical carcinoma of the uterus

A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

A prospective algorithm to reduce anastomotic leaks after rectosigmoid resection for gynecologic malignancies

A Prospective Controlled Trial of Early Postoperative Oral Intake Following Major Abdominal Gynecologic Surgery

Accelerating gastrointestinal recovery in women undergoing ovarian cancer debulking: A randomized, double-blind, placebo-controlled trial

Allelic Losses at Chromosome 3p Are Seen in Human Papilloma Virus 16 Associated Transitional Cell Carcinoma of the Cervix

An analysis of 84,244 patients from the British Columbia cytology-colposcopy program

An integrated molecular profile of endometrioid ovarian cancer

Apoptosis May Be an Early Event of Progestin Therapy for Endometrial Hyperplasia

Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

BARD1, a possible biomarker for breast and ovarian cancer

SHOW MORE ARTICLES

Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy

Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue

Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women

Clinical trial methodology in rare gynecologic tumor research: Strategies for success

Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix

Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus

Comparative study of laparoscopico-vaginal radical hysterectomy and abdominal radical hysterectomy in patients with early cervical cancer

Conservative surgery for borderline ovarian tumors: A review

Cystadenocarcinoma of the abdominal wall following caesarean section: case report and review of the literature

Development and Assessment of a General Theory of Cervical Carcinogenesis Utilizing a Severe Combined Immunodeficiency Murine-Human Xenograft Model

Diagnosis and management of growing teratoma syndrome after ovarian immature teratoma: A single center experience

Disparities in care among patients with low-grade serous ovarian carcinoma

Comments

No comments ... Be the first to comment!

Publication speed

Review quality

Edition and editorial team

Paper Link

Attach one of your papers. We need to confirm that you have had a relation with this journal in order to review its service.